Study of a new hair loss treatment in healthy adults
Part of Skin clinical trials.
This trial tests a new medication called ABS-201 for hair loss. It will first see if the medicine is safe in healthy people, then test if it helps those with male or female pattern baldness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be generally healthy, with no major medical conditions.
- You must be between 18 and 32 body mass index (BMI), weighing more than 60 kilograms.
- You must be willing to avoid pregnancy during the study.
- If you have hair loss, you must have a specific pattern (Norwood-Hamilton III vertex to V for men, or Ludwig I-3 to II-2 for women).
- You must not have used certain hair loss treatments recently, such as minoxidil or finasteride.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called OLX72021 for male pattern hair loss (androgenetic alopecia). It aims to see if the drug is safe and effective in healthy men with mild to moderate hair loss.
This trial tests a once-daily scalp solution called KX-826 to help men with typical male pattern baldness grow hair and slow hair loss. It compares the active solution to a placebo (no active ingredient) to see if it works and is safe.
This research study examines what causes male pattern baldness (androgenetic alopecia) by studying hair, skin, and biological samples from men with hair loss and healthy men. The goal is to better understand why hair loss happens so scientists can develop better treatments.
This trial tests a new treatment (DA-001) to reduce hair shedding and help hair grow back in people with telogen effluvium—a temporary hair loss condition. The treatment is applied directly to the scalp, and participants will be followed to see how well it works.
This trial tests a new treatment for male pattern baldness (androgenic alopecia). It is for men with a moderate level of hair loss who have not used any hair loss treatments in the last 90 days.
This study tests an experimental medication (CKD-843) for men with male pattern baldness. It aims to see if the treatment is safe and effective for regrowing hair.
Hear when a new Androgenetic Alopecia (AGA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.